Hypertension is an important issue in Asia. Prof. Zhu and Korean researchers found that in Chinese and Korean patients with moderate-to-severe hypertension, treatment with T80/H25 provided large reductions in mean SBP and DBP, and high BP goal attainment rates. This once-daily combination is effective and well tolerated in this patient group.
↧